Paul F. Resnick
2016
In 2016, Paul F. Resnick earned a total compensation of $600.3K as Vice President, Chief Business Officer at MabVax Therapeutics Holdings.
Compensation breakdown
| Bonus | $44,094 |
|---|---|
| Option Awards | $323,532 |
| Salary | $212,000 |
| Other | $20,680 |
| Total | $600,306 |
Resnick received $323.5K in option awards, accounting for 54% of the total pay in 2016.
Resnick also received $44.1K in bonus, $212K in salary and $20.7K in other compensation.
Rankings
In 2016, Paul F. Resnick's compensation ranked 10,534th out of 14,075 executives tracked by ExecPay. In other words, Resnick earned more than 25.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,534 out of 14,075 | 25th |
Division Manufacturing | 4,078 out of 5,486 | 26th |
Major group Chemicals And Allied Products | 1,447 out of 1,900 | 24th |
Industry group Drugs | 1,162 out of 1,543 | 25th |
Industry Pharmaceutical Preparations | 903 out of 1,173 | 23rd |
Source: SEC filing on May 2, 2017.
Resnick's colleagues
We found three more compensation records of executives who worked with Paul F. Resnick at MabVax Therapeutics Holdings in 2016.